Mendelsohn Adam 4
4 · Vivani Medical, Inc. · Filed May 14, 2025
Insider Transaction Report
Form 4
Mendelsohn Adam
DirectorChief Executive Officer
Transactions
- Award
Common Stock Option
2025-05-12+200,000→ 200,000 totalExercise: $1.03Exp: 2035-05-11→ Common Stock (200,000 underlying) - Award
RSUs
2025-05-12+100,000→ 100,000 total→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.
- [F3]The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.